Previous close | 137.55 |
Open | 137.42 |
Bid | 135.81 x 800 |
Ask | 135.86 x 1100 |
Day's range | 135.35 - 137.42 |
52-week range | 119.59 - 145.58 |
Volume | |
Avg. volume | 1,035,668 |
Market cap | 15.146B |
Beta (5Y monthly) | 0.89 |
PE ratio (TTM) | 18.35 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.00 (2.18%) |
Ex-dividend date | 05 Apr 2024 |
1y target est | N/A |
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
A week ago, Quest Diagnostics Incorporated ( NYSE:DGX ) came out with a strong set of first-quarter numbers that could...